awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34031219-33E185DF-8793-47C0-A2BF-79ADEBD19016
Q34031219-33E185DF-8793-47C0-A2BF-79ADEBD19016
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34031219-33E185DF-8793-47C0-A2BF-79ADEBD19016
C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma
P2860
Q34031219-33E185DF-8793-47C0-A2BF-79ADEBD19016
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34031219-33E185DF-8793-47C0-A2BF-79ADEBD19016
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66642e7f37209c1d8b75a1c58382785f648a6df0
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.